Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Irani

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 11, 2006
[Current role of chemotherapy in the treatment of hormone-resistant prostatic cancer]Michel Soulie, Philippe Beuzeboc, Jacques Irani, et al.
Histopathology|May 25, 2013
Ductal carcinoma of the prostate shows a different immunophenotype from high grade acinar cancerPauline Jardel, Celine Debiais, Julie Godet, et al.
BJU International|July 13, 2006
Effect of dutasteride on the symptoms of benign prostatic hyperplasia, and patient quality of life and discomfort, in clinical practiceFrançois Desgrandchamps, Stephane Droupy, Jacques Irani, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 5, 2002
[Renal adenocarcinoma in a two and a half year old child: Diagnosis, therapeutic management and 10-year followup]Christophe Pires, Jacques Irani, Frédéric Ouaki, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 3, 2003
[Sensitivity of abdominal radiography without preparation compared with computed tomography in the assessment of residual fragments after percutaneous nephrolithotomy]Christophe Pires, Frédéric Machet, Laurent Dahmani, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 22, 2003
[Prevalence of osteoporotic fractures in patients treated by androgen blockade for prostate cancer]Laurent Dahmani, Bernd Wagner, Charlotte Auzanneau, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2012
DNA-PKcs expression predicts response to radiotherapy in prostate cancerPatrick Bouchaert, Stephane Guerif, Celine Debiais, et al.
BJU International|October 12, 2013
Can we improve the definition of high-risk, hormone naïve, non-metastatic prostate cancer?Bertrand Tombal, Antonio Alcaraz, Nicholas James, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 22, 2004
[International comparison of guidelines for the management of benign prostatic hyperplasia: use of a validated generic tool]Jacques Irani, Christian Brown, Jan Van der Meulen, et al.
Annales De Pathologie|November 25, 2015
[Metastatic lymph node collision of a prostatic adenocarcinoma and an urothelial carcinoma and review of the literature]Audelaure Junca, Eric Frouin, Jacques Irani, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 11, 2006
[Current role of chemotherapy in the treatment of hormone-resistant prostatic cancer]Michel Soulie, Philippe Beuzeboc, Jacques Irani, et al.
Histopathology|May 25, 2013
Ductal carcinoma of the prostate shows a different immunophenotype from high grade acinar cancerPauline Jardel, Celine Debiais, Julie Godet, et al.
BJU International|July 13, 2006
Effect of dutasteride on the symptoms of benign prostatic hyperplasia, and patient quality of life and discomfort, in clinical practiceFrançois Desgrandchamps, Stephane Droupy, Jacques Irani, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 5, 2002
[Renal adenocarcinoma in a two and a half year old child: Diagnosis, therapeutic management and 10-year followup]Christophe Pires, Jacques Irani, Frédéric Ouaki, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 3, 2003
[Sensitivity of abdominal radiography without preparation compared with computed tomography in the assessment of residual fragments after percutaneous nephrolithotomy]Christophe Pires, Frédéric Machet, Laurent Dahmani, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 22, 2003
[Prevalence of osteoporotic fractures in patients treated by androgen blockade for prostate cancer]Laurent Dahmani, Bernd Wagner, Charlotte Auzanneau, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2012
DNA-PKcs expression predicts response to radiotherapy in prostate cancerPatrick Bouchaert, Stephane Guerif, Celine Debiais, et al.
BJU International|October 12, 2013
Can we improve the definition of high-risk, hormone naïve, non-metastatic prostate cancer?Bertrand Tombal, Antonio Alcaraz, Nicholas James, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 22, 2004
[International comparison of guidelines for the management of benign prostatic hyperplasia: use of a validated generic tool]Jacques Irani, Christian Brown, Jan Van der Meulen, et al.
Annales De Pathologie|November 25, 2015
[Metastatic lymph node collision of a prostatic adenocarcinoma and an urothelial carcinoma and review of the literature]Audelaure Junca, Eric Frouin, Jacques Irani, et al.
Pageof 12